Shilpa Medicare said that ANVISA-Brazil successfully completed good manufacturing practice (GMP) inspection at its subsidiary, Shilpa Pharma Lifesciences’ Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II situated in Karnataka.
Posts in category Business Standard
Shilpa Medicare subsidiary’s Karnataka facility clears GMP inspection (10-07-2024)
Shilpa Medicare said that ANVISA-Brazil successfully completed good manufacturing practice (GMP) inspection at its subsidiary, Shilpa Pharma Lifesciences’ Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II situated in Karnataka.
Nifty slides below 24,250; media shares under pressure (10-07-2024)
At 10:30 ST, the barometer index, the S&P BSE Sensex, was down 617.07 points or 0.77% to 79,734.57. The Nifty 50 index shed 191.95 points or 0.79% to 24,241.25.
Nifty slides below 24,250; media shares under pressure (10-07-2024)
At 10:30 ST, the barometer index, the S&P BSE Sensex, was down 617.07 points or 0.77% to 79,734.57. The Nifty 50 index shed 191.95 points or 0.79% to 24,241.25.
Bansal Wire makes stellar debut; lists at 39% premium over issue price (10-07-2024)
The stock listed at Rs 356, a 39 per cent premium over its issue price of Rs 256 per share on the National Stock Exchange NSE on Wednesday.
Wire stocks rally: Polycab, Finolex gain up to 200% in 18 mths; key levels (10-07-2024)
Most of the stocks are now seen testing the 20-DMA; trade along this key moving average is likely to dictate the near-term trend for electric wire-related stocks; suggest charts.
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock? (10-07-2024)
Emcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a reasonable valuation with a niche opportunity to invest in the gynaecology & HIV antivirals therapeutic areas
Emcure Pharma listing: Stock makes solid debut on NSE, BSE with 31% premium (10-07-2024)
Emcure Pharmaceuticals listing: Stock made a strong market debut as they got listed at Rs 1,325, a 31 per cent premium over the issue price of Rs 1,008 on the NSE and BSE today
Marathon Realty slumps after pre-sales volume drops 45% YoY in Q1 (10-07-2024)
Marathon Nextgen Realty tumbled 4.58% to Rs 594.95 after the company’s pre-sales area declined by 45% to 79,239 square feet in Q1 FY25 from 1,43,429 square feet in Q1 FY24.
RVNL surges 10% on multiple order wins; stock up over 200% thus far in 2024 (10-07-2024)
The company also signed MoU with TATWEER Middle East and Africa LLC for using RVNL’s expertise in railway sector.